Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Partially Double- Blind, Active Control Study to Compare the Immunogenicity and Safety of a Liquid Formulation of ROTAVIN With the Currently Licensed Frozen Formulation of the Vaccine (ROTAVIN-M1), in Healthy Vietnamese Infants

NCT03703336 is registered in ClinicalTrials.gov with Center for Research and Production of Vaccines and Biologicals, Vietnam as lead sponsor.

NCT NCT03703336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03703336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Partially Double- Blind, Active Control Study to Compare the Immunogenicity and Safety of a Liquid Formulation of ROTAVIN With the Currently Licensed Frozen Formulation of the Vaccine (ROTAVIN-M1), in Healthy Vietnamese Infants
Lead sponsor
Center for Research and Production of Vaccines and Biologicals, Vietnam
Phase
Phase 3
Overall status
Completed
Start date
March 16, 2019
Completion date
January 8, 2020
Enrollment
825 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, diarrhea rotavirus